| |
|
|
|
Immunogen Inc  
|
|
7.46 0.08 (0.01%) |
01-25 11:10 |
|
Open: |
7.34 |
Pre close: |
7.38 |
Target:
|
9.46
|
|
High: |
7.695 |
Low: |
7.32 |
Resistance:
|
8.10
9.46
|
|
Volume: |
512,782 |
Market Cap: |
1453M |
Support:
|
6.97
6.27
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.69
 |
MACD |
MACD(12,26):
|
0.30  |
|
MA(20): |
7.11 |
Signal(12,26,9): |
0.27 |
|
MA(100): |
5.61 |
Stochastic Oscillator |
%K(14,3):
|
69.60 |
|
MA(250): |
4.78 |
%D(3): |
76.39 |
|
Average Volume(K) |
3-Month: |
242267
|
52-Week |
High:
|
8.10 |
|
10-Days: |
236224 |
Low: |
1.95 |
|
RSI |
RSI(14):
|
58.74 |
Change(%): |
61.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.430 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
194.71 |
|
EPS Est. Current Year |
-0.720 |
Return on Assets (ttm) |
-12.0 |
Shares Float (M) |
176.17 |
|
EPS Est. Next Year |
-1.380 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.54 |
|
EPS Est. Next Quarter |
-0.240 |
Qtrly Rev. Growth |
37.0 |
% Held by Institutions |
73.63 |
|
Forward EPS |
-0.700 |
Gross Profit (p.s.) |
-0.166 |
Shares Short (K) |
22790 |
|
Book Value (p.s.) |
-0.250 |
EBITDA (p.s.) |
-0.237 |
P/E |
-17.68 |
|
Sales Per Share |
0.469 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-30.40 |
|
Profit Margin |
-77.65 |
Operating Cash Flow
(M) |
-119.71 |
P/S |
16.20 |
|
Operating Margin |
-52.94 |
Levered Free Cash Flow
(M) |
-30.09 |
P/CF |
-12.36 |
|
|
|
|
|
|
